RxDoctor Payments Data

Jennifer Ramsey

Psychiatric/Mental Health · Anderson, SCNPI 1558788281

Payments from drug & device makers

$1,236in general payments, 2019–2025

Across 38 payments — averaging $32.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$399
  • Otsuka America Pharmaceutical, Inc.$248
  • Mylan Specialty L.p.$238
  • Axsome Therapeutics, Inc.$180
  • Inari Medical, Inc.$58
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$27
  • plus $88 from 4 others

What the payments were for

  • Food & beverage$1,236100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,236 in reported general payments places this provider in the 60th percentile of 354 psychiatric/mental health providers in South Carolina.

See all psychiatric/mental health providers in South Carolina

Medicare billing

Part B allowed, 2024
$8,443
Medicare patients
26
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl14$19,457
Fluoxetine Hcl38$2,130
Divalproex Sodium16$2,029
Divalproex Sodium ErDivalproex Sodium19$1,495
Duloxetine Hcl42$1,260
Aripiprazole32$764
Mirtazapine14$671
Escitalopram Oxalate49$623
Bupropion XlBupropion Hcl26$540
Hydroxyzine Hcl20$517
Trazodone Hcl48$498
Venlafaxine Hcl ErVenlafaxine Hcl36$495
Olanzapine20$484
Buspirone Hcl25$468
Quetiapine Fumarate53$332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$21$19,45714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 354 psychiatric/mental health providers in South Carolina.

Other psychiatric/mental health in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →